| http://dbpedia.org/ontology/abstract
|
Regulus Therapeutics Inc. or Regulus (Nasd … Regulus Therapeutics Inc. or Regulus (Nasdaq: RGLS) is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. Pharmaceuticals and Isis Pharmaceuticals.
|
| http://dbpedia.org/ontology/foundingYear
|
2007
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/ontology/location
|
http://dbpedia.org/resource/San_Diego%2C_California +
|
| http://dbpedia.org/ontology/numberOfEmployees
|
30
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
http://www.regulusrx.com/ +
, http://www.regulusrx.com +
|
| http://dbpedia.org/ontology/wikiPageID
|
32446059
|
| http://dbpedia.org/ontology/wikiPageLength
|
4762
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1121765250
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Hepatitis_C +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Alport_syndrome +
, http://dbpedia.org/resource/MicroRNAs +
, http://dbpedia.org/resource/Sanofi +
, http://dbpedia.org/resource/Biotechnology +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
, http://dbpedia.org/resource/San_Diego%2C_California +
, http://dbpedia.org/resource/GlaxoSmithKline +
, http://dbpedia.org/resource/Category:Health_care_companies_based_in_California +
|
| http://dbpedia.org/property/foundation
|
September 2007
|
| http://dbpedia.org/property/homepage
|
http://www.regulusrx.com/ +
|
| http://dbpedia.org/property/industry
|
http://dbpedia.org/resource/Biotechnology +
|
| http://dbpedia.org/property/keyPeople
|
Jay Hagan, President and CEO; Denis Drygin, Ph.D., Chief Scientific Officer; Cris Calsada, CFO;
|
| http://dbpedia.org/property/location
|
San Diego, California, USA
|
| http://dbpedia.org/property/name
|
Regulus Therapeutics Inc.
|
| http://dbpedia.org/property/numEmployees
|
30
|
| http://dbpedia.org/property/products
|
microRNA therapeutics
|
| http://dbpedia.org/property/tradedAs
|
NASDAQ:RGLS
|
| http://dbpedia.org/property/type
|
Public
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Authority_control +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Verification +
, http://dbpedia.org/resource/Template:When +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Health_care_companies_based_in_California +
, http://dbpedia.org/resource/Category:Pharmaceutical_companies_of_the_United_States +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_Nasdaq +
|
| http://schema.org/sameAs
|
http://viaf.org/viaf/232503976 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Regulus_Therapeutics?oldid=1121765250&ns=0 +
|
| http://xmlns.com/foaf/0.1/homepage
|
http://www.regulusrx.com/ +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Regulus_Therapeutics +
|
| http://xmlns.com/foaf/0.1/name
|
Regulus Therapeutics Inc.
|
| owl:sameAs |
http://viaf.org/viaf/232503976 +
, http://dbpedia.org/resource/Regulus_Therapeutics +
, http://www.wikidata.org/entity/Q7309716 +
, https://global.dbpedia.org/id/4tSwV +
, http://rdf.freebase.com/ns/m.05c6wzw +
, http://yago-knowledge.org/resource/Regulus_Therapeutics +
|
| rdf:type |
http://dbpedia.org/class/yago/WikicatPharmaceuticalCompaniesOfTheUnitedStates +
, http://www.wikidata.org/entity/Q24229398 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://dbpedia.org/class/yago/Institution108053576 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://dbpedia.org/class/yago/YagoLegalActorGeo +
, http://dbpedia.org/class/yago/YagoLegalActor +
, http://dbpedia.org/ontology/Company +
, http://schema.org/Organization +
, http://www.wikidata.org/entity/Q43229 +
, http://dbpedia.org/ontology/Agent +
, http://dbpedia.org/class/yago/DrugCompany108002578 +
, http://www.wikidata.org/entity/Q4830453 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/ontology/Organisation +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
, http://dbpedia.org/class/yago/Company108058098 +
, http://dbpedia.org/class/yago/SocialGroup107950920 +
, http://dbpedia.org/class/yago/Group100031264 +
, http://dbpedia.org/class/yago/Organization108008335 +
|
| rdfs:comment |
Regulus Therapeutics Inc. or Regulus (Nasd … Regulus Therapeutics Inc. or Regulus (Nasdaq: RGLS) is a clinical stage biopharmaceutical company focused on the development of first-in-class drugs that target microRNAs to treat a broad range of diseases. Regulus was established in September 2007 by Alnylam Pharmaceuticals and Isis Pharmaceuticals. Pharmaceuticals and Isis Pharmaceuticals.
|
| rdfs:label |
Regulus Therapeutics
|
